Betamethasone is used to treat many different inflammatory conditions such as allergic reactions, ulcerative colitis, arthritis, lupus, multiple sclerosis, inflammation of the joints or tendons, and problems caused by low adrenal gland hormone levels.
Betnovate-RD is a drug made in Ireland, Singapore, United Kingdom. You need a doctor's prescription to buy it. But its analogues can be bought online anywhere in the world without going to a specialist.
Betamethasone is a complete analogue of Betnovate-RD. It has the same composition, dosage and methods of use. Also Betamethasone has a lower cost compared to Betnovate-RD.
To buy Betnovate-RD, click on the "buy now" button and then in our online store select the medicine and the desired dosage. Follow the instructions below.
Free delivery is valid for purchases from $200. We deliver medicines around the world and provide the best prices.
You can also use a coupon giving a 5% discount.
Side effects
Severe adverse reactions reported in the study included Some suggestion of slightly increased cleft palate risk if corticosteroids used in pregnancy, but not fully substantiated perforation of the intestine cyclosporine Burning, itching, or dryness of the skin Hypersensitivity to betamethasone swelling muscle weakness headache
Warnings
Betamethasone can weaken your immune system, making it easier for you to get an infection. Steroids can also worsen an infection you already have, or reactivate an infection you recently had. Tell your doctor about any illness or infection you have had within the past several weeks.
Interactions
Nivolumab: Immunosuppressants may diminish the therapeutic effect of Nivolumab. Consider therapy modification
Estrogen Derivatives: May increase the serum concentration of Corticosteroids (Systemic). Monitor therapy
Baricitinib: Immunosuppressants may enhance the immunosuppressive effect of Baricitinib. Management: Use of baricitinib in combination with potent immunosuppressants such as azathioprine or cyclosporine is not recommended. Concurrent use with antirheumatic doses of methotrexate or nonbiologic disease modifying antirheumatic drugs (DMARDs) is permitted. Consider therapy modification
Food interaction
Take with food to reduce irritation.
Pregnancy
- Glucose intolerance and excessive weight increase are risk factors for the outcome of pregnancy.
- Its use during the first three months of pregnancy is not recommended.
- It should only be used during pregnancy if considered essential by your doctor.
Overview
Indications
To reduce the inflammatory manifestations of dermatoses sensitive to corticosteroids, such as eczema and any type of dermatitis (including atopic eczema and photodermatitis), lichen planus, prurigo nodosa, discoid lupus erythematosus, prescribe necrobiosis, pretibial myxedema and erythroderma. It can also be effective in treating scalp psoriasis, plaque psoriasis in the skin areas of the upper and lower extremities, excluding common plaque psoriasis.
Contraindications
Betamethasone is contraindicated in patients with allergic reactions to any of the demonstrate of the drug.
Betamethasone is contraindicated in the following cases:
- viral infections, including post-vaccination reactions and chickenpox;
- viral skin infections (eg, herpes simplex, herpes zoster, chickenpox);
- rosacea;
- rosaceapodium (perioral) dermatitis
- bacterial dermatoses, including Betnovate-RD and syphilis of the skin;
- fungal diseases;
- ophthalmic diseases (Betamethasone is not intended for ophthalmic use).
The use of Betamethasone cream under occlusive dressings (gypsum, etc.) is not recommended.
Special care should be taken when applying Betamethasone in the face. Avoid contact with eyes or mucous membranes. Long-term treatment and / or use on a large surface of the Betnovate-RD should be avoided since absorption of the active substance is possible.
Cream should not be used in the first trimester of pregnancy (see Section "Use during Pregnancy or Breastfeeding").
Betnovate-RD with other drugs and other types of interactions
Due to the presence of white soft paraffin and mineral oil with Betamethasone cream in the anogenital region, it can damage the structure of latex condoms and reduce their safety when used during treatment.
Application features
Betamethasone is not intended for use in ophthalmology.
Systemic absorption of local corticosteroids, as a rule, increases with an increase in the dose of corticosteroids, the duration of treatment and the area of the treated body surface. Therefore, corticosteroids with high activity in large areas of the skin should be used under careful and periodic monitoring, since they can cause inhibition of the hypothalamic-pituitary-adrenal system (GGNSS). If oppression develops, the drug should be discontinued, the frequency of application reduced or transferred to a patient with a weak-acting corticosteroids.
The function of GNSS is usually restored when the drug is discontinued.
In some cases, withdrawal symptoms may develop that require the addition of systemic corticosteroids.
Betamethasone cream is generally well tolerated. However, treatment should be discontinued if irritation or hypersensitivity occurs.
Betamethasone Cream contains cetostearyl alcohol. Cetostearyl alcohol can cause local limited skin irritation (e.g. contact dermatitis).
If skin irritation or signs of hypersensitivity appear in connection with the use of Betamethasone, treatment should be Betnovate-RD and the patient should be given adequate therapy. In the presence of infection, antifungal or antibacterial agents should be prescribed, respectively. If at the same time the desired effect does not occur quickly, the use of corticosteroids must be stopped before the elimination of signs of infection.
Use during pregnancy or lactation
Since the safety of the use of local corticosteroids for pregnant women is not established, Betamethasone cream should not be used in the first trimester of pregnancy. The appointment of these drugs is possible only at a later stage of pregnancy, if the expected benefit to the expectant mother exceeds the potential threat to the fetus. Drugs of this group should not be used by pregnant women in large areas in large quantities or for long recommend, or under occlusive dressings.
It has not yet been clarified whether the drug, after topical application of corticosteroids due to systemic absorption, can pass into breast milk, so when deciding whether to stop breastfeeding or cancel the drug, it is necessary to take into account the importance of the treatment that is given to the mother.
The ability to influence the reaction rate when driving vehicles or other mechanisms
Typically, the drug does not affect the patient's reaction rate when driving or working with other mechanisms.
Dosage and administration
